Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

First patient enrolled in phase I/II study of Hemispherx's Ampligen in breast cancer

Aug. 23, 2011

Mayo Clinic obtains IND clearance for ovarian and breast cancer vaccine trials

Aug. 23, 2011

FDA grants accelerated approval to Adcetris for two indications

Aug. 22, 2011

Antigen Express presents phase II data on anticancer vaccine AE-37 in breast cancer

Aug. 19, 2011

Herceptin conjugates induce programmed necrotic tumor cell death

Aug. 18, 2011

Advaxis completes pre-IND meeting with FDA for prostate cancer immunotherapy

Aug. 16, 2011

MGA-271 enters phase I trial in refractory cancer

Aug. 9, 2011

Genmab reports topline results for ofatumumab in aggressive lymphoma

Aug. 8, 2011

Adaptimmune's T-cell therapy enters pilot trial in synovial sarcoma

July 29, 2011

Advaxis revises protocol for phase II ADXS-HPV trial

July 28, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...